Top

Gepubliceerd in:

01-04-2008 | Artikelen

Goedaardige hersentumoren

Auteurs: Dr. L. J. A. Stalpers, dr. W. R. van Furth

Gepubliceerd in: Bijblijven | Uitgave 4/2008

Samenvatting

Ieder jaar wordt in Nederland bij zeven- à achthonderd patiënten een goedaardige tumor van het centraal zenuwstelsel vastgesteld. Het aantal langdurige overlevers is een veelvoud daarvan. Ondanks de goede genezingskansen houden veel patiënten (15-50%) blijvend neurologische en psychosociale beperkingen ten gevolge van de aandoening en/of de behandeling.

Naast neurologische uitval en epilepsie komen chronische denkstoornissen, stemmingsstoornissen en moeheid veel voor; deze worden soms pas laat ontdekt. Ook het gebruik van anti-epileptica op zichzelf is een risicofactor voor cognitieve achteruitgang en verminderde kwaliteit van leven. Radiotherapie is een belangrijke risicofactor voor mentale achterstand bij kinderen met een hersentumor; bij volwassenen is de cognitieve schade door neurochirurgie en bestraling minder opvallend dan de schade door de tumor.

vorige artikel Langdurig overleven na een behandeling voor testiskanker

volgende artikel Psychosociale gevolgen van en hulp bij chronische kanker

Visser O. What is cancer? Epidemiology of benign CNS tumours. In: Stalpers L, Dirven C, Boogerd W, editors. Proceedings of the 66th Oncology Day on Benign Brain Tumours. Amsterdam: The Netherlands Cancer Institute, 2008. p. 4.

Vernooij MW, Ikram MA, Tanghe HL, Vincent AJPE, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821-8.

Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM. Epidemiology of intracranial meningioma. Neurosurgery 2005;57:1088-95.

Rockhill J, Mrugala M, Chamberlain MC. Intracranial meningiomas: an overview of diagnosis and treatment. Neurosurg Focus 2007;23:E1.CrossRefPubMed

Simpson D. The recurrence of intracranial meningeomas after surgical treatment. J Neurol Neurosurg Psychiat 1957;20:22-39.CrossRefPubMed

Bateman BT, Pile-Spellman J, Gutin PH, Berman MF. Meningioma resection in the elderly: Nationwide inpatient sample, 1998-2002. Neurosurgery 2005;57:866-72.

Curry WT, McDermott MW, Carter BS, Barker FG. Craniotomy for meningioma in the United States between 1888 and 2000: Decreasing rate of mortality and the effect of provider caseload. J Neurosurg 2005;102:977-86.

Nieuwenhuizen D van, Klein M, Stalpers LJA, Leenstra S, Heimans J, Reijneveld JC. Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol 2007;84:271-8.

Baumert BG, Norton IA, Davis JB. Intensity-modulated stereotactic radiotherapy vs. stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base. Int J Radiat Oncol Biol Phys 2003;57:580-92.

10.

Cozzi L, Clivio A, Bauman G, Cora S, Nicolini G, Pellegrini R, et al. Comparison of advanced irradiation techniques with photons for benign intracranial tumours. Radiother Oncol 2006;80:268-73.

11.

Baumert BG, Villà S, Studer G, Mirimanoff RO, Davis JB, Landau K, et al. Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma. Radiother Oncol 2004;72:169-74.

12.

Saeed P, Rootman J, Nugent RA, White VA, Mackenzie IR, Koornneef L. Optic nerve sheath meningioma. Ophtalmology 2003;110:2019-30.

13.

Forbes AR, Goldberg ID. Radiation therapy in the treatment of meningioma: The Joint Center for Radiation Therapy experience 1970 to 1982. J Clin Oncol 1984;2:1139-43.

14.

Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: Analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985;62:18-24.CrossRefPubMed

15.

Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM. Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 1987;20:525-8.

16.

Taylor BW, Jr., Marcus RB, Jr., Friedman WA, Ballinger WE, Jr., Million RR. The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 1988;15:299-304.PubMed

17.

Glaholm J, Bloom HJ, Crow JH. The role of radiotherapy in the management of intracranial meningiomas: The Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 1990;18:775-61.

18.

Miralbell R, Linggood RM, de la Monte MS, Convery K, Munzenrider JE, Mirimanoff RO. The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol 1992;13:157-64.

19.

Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas: A retrospective analysis of 140 patients treated from 1967 to 1990 [published erratum appears in J Neurosurg 1994;80:777]. J Neurosurg 1994; 80:195-201.CrossRefPubMed

20.

Mahmood A, Qureshi NH, Malik GM. Intracranial meningiomas: Analysis of recurrence after surgical treatment. Acta Neurochir (Wien) 1994;126:53-8.

21.

Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB, Jr., Rhoton AL. Benign meningiomas: Primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 1997;39:427-36.

22.

Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, et al. Primarily resected meningiomas: Outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 1998;73:936-42.

23.

Nutting C, Brada M, Brazil L, Sibtain A, Saran F, Westbury C, et al. Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg 1999;90:823-7.

24.

Kondziolka D, Levy EI, Niranjan A, Flickinger JC, Lunsford LD. Long-term outcomes after meningioma radiosurgery: physician and patient perspectives. J Neurosurg 1999;91: 44-50.CrossRefPubMed

25.

Dufour H, Muracciole X, Metellus P, Regis J, Chinot O, Grisoli F. Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: Is there an alternative to aggressive tumor removal? Neurosurgery 2001;48:285-94.

26.

Debus J, Wuendrich M, Pirzkall A, Hoess A, Schlegel W, Zuna I, et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: Long-term results. J Clin Oncol 2001;19:3547-53.

27.

Tucha O, Smely C, Preier M, Becker G, Paul GM, Lange KW. Preoperative and postoperative cognitive functioning in patients with frontal meningiomas. J Neurosurg 2003;98:21-31.CrossRefPubMed

28.

Dijkstra M, Nieuwenhuizen D van, Stalpers LJA, Wumkes M, Waagemans M, Leenstra S, et al. Late cognitive sequelae in WHO grade I meningioma patients. J Neurol Neurosurg Psych 2008 (accepted for publication).

29.

Jacoby A, Gamble C, Doughty J, Marson A, Chadwick D; Medical Research Council MESS Study Group. Quality of life outcomes of immediate or delyed treatment of early epilepsy end single seizures. Neurology 2007;68:1188-96.

30.

Breemen MSM van, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: Epidemiology, mechanisms, and management. Lancet Neurol 2007;6:421-30.

31.

Butler JM, Rapp SR, Shaw EG. Managing the cognitive effects of brain tumor radiation therapy. Curr Treat Options Oncol 2006;7:517-23.

32.

Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998;16:2522-7.

33.

Kaleita TA, Wellisch DK, Graham CA, Steh B, Nghiemphu P, Ford JM, et al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. ASCO Meeting Abstracts 2006;24:1503.

34.

Shaw EG, Rosdhal R, D’Agostino RB Jr, Lovato J, Naughton MJ, Robbins ME, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 2006;24:1415-20.

35.

Rutten I, Baumert BG, Seidel L, Kotolenko S, Collignon J, Kaschten B, et al. Long-term follow-up reveals low toxicity of radiosurgery for vestibular schwannoma. Radiother Oncol 2007;82:83-9.

36.

Samii A, Lenarz M, Majdani O, Lim HH, Samii M, Lenarz T. Auditory midbrain implant: A combined approach for vestibular schwannoma surgery and device implantation. Otol Neurotol 2007;28:31-8.

37.

Gupta N, Banerjee A, Haas-Kogan D, editors. Pediatric CNS tumors. Berlin: Springer, 2004.

38.

Grill J, Renaux VK, Bulteau C, Viguier D, Levy-Piebois C, Sainte-Rose C, et al. Long-term intellectual outcome in children with posterior fossa according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 1999;45:137-45.

39.

Beebe DW, Ris MD, Armstrong D, Fontanesi J, Mulhern R, Holmes E, et al. Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: Evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130). J Clin Oncol 2005;23:5198-204.

Titel: Goedaardige hersentumoren
Auteurs: Dr. L. J. A. Stalpers
dr. W. R. van Furth
Publicatiedatum: 01-04-2008
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Bijblijven / Uitgave 4/2008
Print ISSN: 0168-9428
Elektronisch ISSN: 1876-4916
DOI: https://doi.org/10.1007/BF03076347

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 4/2008

De acute en chronische leukemieën, het hodgkinlymfoom en de non-hodgkinlymfomen

Nacontrole bij kanker: ook een taak voor de huisarts

Borstkanker

Psychosociale problemen bij adolescente kinderen van kankerpatiënten

De prognose van (ex-)kankerpatiënten verbetert veelal met elk overleefd jaar

Langdurig overleven na een behandeling voor testiskanker